Refreshing results…
DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc 1
UploadIdentification of Resistance Determinants for a Promising Antileishmanial Oxaborole Series
Download from doi.orgMissing publications? Search for publications with a matching author name.